Mark Emkjer New CEO of Accelrys, Steven Rash Heads Power3, David U Prichard Joins Invitrogen s Board, and Others | GenomeWeb

Mark Emkjer has become president and CEO of Accelrys, formerly Pharmacopeia, the company said last week. He was also elected to the company's board of directors. Emkjer had been Accelrys' president since the end of 2002. Previously, he was president and COO of Sunquest Information Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.